P. Montero

发表

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms

J. Cortijo, P. Montero, J. Milara, 2021, International journal of molecular sciences.

MUC1 intracellular bioactivation mediates lung fibrosis

J. Escrivá, J. Cortijo, P. Montero, 2019, Thorax.

MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway

J. Cortijo, P. Montero, J. Milara, 2021, International journal of molecular sciences.

Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients

J. Pérez-Fidalgo, A. Cervantes, J. Cortijo, 2022, Cancers.

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension

J. Cortijo, P. Montero, J. Milara, 2021, International journal of molecular sciences.

The JAK2 pathway is activated in idiopathic pulmonary fibrosis

J. Escrivá, M. Molina-Molina, J. Cortijo, 2018, Respiratory Research.

Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

J. Signes-Costa, P. Montero, Inés Roger, 2022, Biomedicines.

Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model

J. Cortijo, P. Montero, J. Milara, 2022, International journal of molecular sciences.

Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro

J. Pérez-Fidalgo, J. Cortijo, P. Montero, 2022, Pharmaceuticals.

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis

J. Escrivá, J. Cortijo, P. Montero, 2022, Respiratory Research.

MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease

J. Cortijo, P. Montero, J. Milara, 2018, Respiratory Research.

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview

J. Cortijo, P. Montero, J. Milara, 2023, Cancers.

N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro

J. Cortijo, P. Montero, J. Milara, 2022, International journal of molecular sciences.

Influence of dose and exposition time in the effectiveness of N-Acetyl-l-cysteine treatment in A549 human epithelial cells

J. Cortijo, P. Montero, J. Milara, 2023, Heliyon.

Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies

J. Cortijo, P. Montero, J. Milara, 2022, International journal of molecular sciences.

Paclitaxel alters melanogenesis and causes pigmentation in the skin of gynecological cancer patients

J. Pérez-Fidalgo, J. Cortijo, P. Montero, 2023, Fundamental & clinical pharmacology.

Mechanisms underlying corticosteroid resistance in patients with asthma: a review of current knowledge

J. Cortijo, P. Montero, J. Milara, 2023, Expert review of respiratory medicine.

Targeting IL‐11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension‐associated lung fibrosis

J. Escrivá, J. Cortijo, P. Montero, 2024, British journal of pharmacology.

Targeting IL-11 system as a treatment of pulmonary arterial hypertension.

J. Escrivá, J. Cortijo, P. Montero, 2023, Pharmacological research.

Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11.

J. Cortijo, P. Montero, J. Milara, 2024, European journal of pharmacology.

Phosphodiesterase 4 is overexpressed in keloid epidermal scars and its inhibition reduces keratinocyte fibrotic alterations

P. Montero, J. Milara, Pilar Ribera, 2024, Molecular medicine.

Damaging effects of UVA, blue light, and infrared radiation: in vitro assessment on a reconstructed full-thickness human skin

J. Cortijo, P. Montero, J. Milara, 2023, Frontiers in medicine.